Literature DB >> 27806295

Differences in Allelic Frequency and CDRH3 Region Limit the Engagement of HIV Env Immunogens by Putative VRC01 Neutralizing Antibody Precursors.

Christina Yacoob1, Marie Pancera2, Vladimir Vigdorovich3, Brian G Oliver3, Jolene A Glenn1, Junli Feng1, D Noah Sather3, Andrew T McGuire1, Leonidas Stamatatos4.   

Abstract

Elicitation of broadly neutralizing antibodies remains a long-standing goal of HIV vaccine research. Although such antibodies can arise during HIV-1 infection, gaps in our knowledge of their germline, pre-immune precursor forms, as well as on their interaction with viral Env, limit our ability to elicit them through vaccination. Studies of broadly neutralizing antibodies from the VRC01-class provide insight into progenitor B cell receptors (BCRs) that could develop into this class of antibodies. Here, we employed high-throughput heavy chain variable region (VH)/light chain variable region (VL) deep sequencing, combined with biophysical, structural, and modeling antibody analyses, to interrogate circulating potential VRC01-progenitor BCRs in healthy individuals. Our study reveals that not all humans are equally predisposed to generate VRC01-class antibodies, not all predicted progenitor VRC01-expressing B cells can bind to Env, and the CDRH3 region of germline VRC01 antibodies influence their ability to recognize HIV-1. These findings will be critical to the design of optimized immunogens that should consider CDRH3 interactions.
Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CDRH3; HIV; VRC01; broadly neutralizing antibodies; germline; human alleles; human antibodies

Mesh:

Substances:

Year:  2016        PMID: 27806295      PMCID: PMC5207042          DOI: 10.1016/j.celrep.2016.10.017

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  48 in total

1.  Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization.

Authors:  Florian Klein; Ron Diskin; Johannes F Scheid; Christian Gaebler; Hugo Mouquet; Ivelin S Georgiev; Marie Pancera; Tongqing Zhou; Reha-Baris Incesu; Brooks Zhongzheng Fu; Priyanthi N P Gnanapragasam; Thiago Y Oliveira; Michael S Seaman; Peter D Kwong; Pamela J Bjorkman; Michel C Nussenzweig
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

2.  Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.

Authors:  Xueling Wu; Zhi-Yong Yang; Yuxing Li; Carl-Magnus Hogerkorp; William R Schief; Michael S Seaman; Tongqing Zhou; Stephen D Schmidt; Lan Wu; Ling Xu; Nancy S Longo; Krisha McKee; Sijy O'Dell; Mark K Louder; Diane L Wycuff; Yu Feng; Martha Nason; Nicole Doria-Rose; Mark Connors; Peter D Kwong; Mario Roederer; Richard T Wyatt; Gary J Nabel; John R Mascola
Journal:  Science       Date:  2010-07-08       Impact factor: 47.728

Review 3.  Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies.

Authors:  Peter D Kwong; John R Mascola
Journal:  Immunity       Date:  2012-09-21       Impact factor: 31.745

4.  Selection pressure on HIV-1 envelope by broadly neutralizing antibodies to the conserved CD4-binding site.

Authors:  Xueling Wu; Charlene Wang; Sijy O'Dell; Yuxing Li; Brandon F Keele; Zhongjia Yang; Hiromi Imamichi; Nicole Doria-Rose; James A Hoxie; Mark Connors; George M Shaw; Richard T Wyatt; John R Mascola
Journal:  J Virol       Date:  2012-03-14       Impact factor: 5.103

5.  The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection.

Authors:  Elin S Gray; Maphuti C Madiga; Tandile Hermanus; Penny L Moore; Constantinos Kurt Wibmer; Nancy L Tumba; Lise Werner; Koleka Mlisana; Sengeziwe Sibeko; Carolyn Williamson; Salim S Abdool Karim; Lynn Morris
Journal:  J Virol       Date:  2011-03-09       Impact factor: 5.103

6.  Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120.

Authors:  Lei Chen; Young Do Kwon; Tongqing Zhou; Xueling Wu; Sijy O'Dell; Lisa Cavacini; Ann J Hessell; Marie Pancera; Min Tang; Ling Xu; Zhi-Yong Yang; Mei-Yun Zhang; James Arthos; Dennis R Burton; Dimiter S Dimitrov; Gary J Nabel; Marshall R Posner; Joseph Sodroski; Richard Wyatt; John R Mascola; Peter D Kwong
Journal:  Science       Date:  2009-11-20       Impact factor: 47.728

7.  Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection.

Authors:  Peter Hraber; Michael S Seaman; Robert T Bailer; John R Mascola; David C Montefiori; Bette T Korber
Journal:  AIDS       Date:  2014-01-14       Impact factor: 4.177

8.  Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.

Authors:  Nicole A Doria-Rose; Chaim A Schramm; Jason Gorman; Penny L Moore; Jinal N Bhiman; Brandon J DeKosky; Michael J Ernandes; Ivelin S Georgiev; Helen J Kim; Marie Pancera; Ryan P Staupe; Han R Altae-Tran; Robert T Bailer; Ema T Crooks; Albert Cupo; Aliaksandr Druz; Nigel J Garrett; Kam H Hoi; Rui Kong; Mark K Louder; Nancy S Longo; Krisha McKee; Molati Nonyane; Sijy O'Dell; Ryan S Roark; Rebecca S Rudicell; Stephen D Schmidt; Daniel J Sheward; Cinque Soto; Constantinos Kurt Wibmer; Yongping Yang; Zhenhai Zhang; James C Mullikin; James M Binley; Rogier W Sanders; Ian A Wilson; John P Moore; Andrew B Ward; George Georgiou; Carolyn Williamson; Salim S Abdool Karim; Lynn Morris; Peter D Kwong; Lawrence Shapiro; John R Mascola
Journal:  Nature       Date:  2014-03-02       Impact factor: 49.962

9.  Increasing the potency and breadth of an HIV antibody by using structure-based rational design.

Authors:  Ron Diskin; Johannes F Scheid; Paola M Marcovecchio; Anthony P West; Florian Klein; Han Gao; Priyanthi N P Gnanapragasam; Alexander Abadir; Michael S Seaman; Michel C Nussenzweig; Pamela J Bjorkman
Journal:  Science       Date:  2011-10-27       Impact factor: 47.728

10.  Toward a more accurate view of human B-cell repertoire by next-generation sequencing, unbiased repertoire capture and single-molecule barcoding.

Authors:  Linling He; Devin Sok; Parisa Azadnia; Jessica Hsueh; Elise Landais; Melissa Simek; Wayne C Koff; Pascal Poignard; Dennis R Burton; Jiang Zhu
Journal:  Sci Rep       Date:  2014-10-27       Impact factor: 4.379

View more
  15 in total

1.  Immunological mechanisms of inducing HIV immunity in infants.

Authors:  Genevieve G Fouda; Kristina De Paris; Ofer Levy; Arnaud Marchant; Glenda Gray; Sallie Permar; Mary Marovich; Anjali Singh
Journal:  Vaccine       Date:  2019-11-21       Impact factor: 3.641

2.  A Potent anti-Simian Immunodeficiency Virus Neutralizing Antibody Induction Associated with a Germline Immunoglobulin Gene Polymorphism in Rhesus Macaques.

Authors:  Saori Matsuoka; Takeo Kuwata; Hiroshi Ishii; Tsuyoshi Sekizuka; Makoto Kuroda; Masato Sano; Midori Okazaki; Hiroyuki Yamamoto; Mikiko Shimizu; Shuzo Matsushita; Yohei Seki; Akatsuki Saito; Hiromi Sakawaki; Vanessa M Hirsch; Tomoyuki Miura; Hirofumi Akari; Tetsuro Matano
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

3.  The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen.

Authors:  Colin Havenar-Daughton; Anita Sarkar; Daniel W Kulp; Laura Toy; Xiaozhen Hu; Isaiah Deresa; Oleksandr Kalyuzhniy; Kirti Kaushik; Amit A Upadhyay; Sergey Menis; Elise Landais; Liwei Cao; Jolene K Diedrich; Sonu Kumar; Torben Schiffner; Samantha M Reiss; Grégory Seumois; John R Yates; James C Paulson; Steven E Bosinger; Ian A Wilson; William R Schief; Shane Crotty
Journal:  Sci Transl Med       Date:  2018-07-04       Impact factor: 17.956

Review 4.  Igh Locus Polymorphism May Dictate Topological Chromatin Conformation and V Gene Usage in the Ig Repertoire.

Authors:  Amy L Kenter; Corey T Watson; Jan-Hendrik Spille
Journal:  Front Immunol       Date:  2021-05-18       Impact factor: 7.561

5.  Modeling Immunity with Rosetta: Methods for Antibody and Antigen Design.

Authors:  Clara T Schoeder; Samuel Schmitz; Jared Adolf-Bryfogle; Alexander M Sevy; Jessica A Finn; Marion F Sauer; Nina G Bozhanova; Benjamin K Mueller; Amandeep K Sangha; Jaume Bonet; Jonathan H Sheehan; Georg Kuenze; Brennica Marlow; Shannon T Smith; Hope Woods; Brian J Bender; Cristina E Martina; Diego Del Alamo; Pranav Kodali; Alican Gulsevin; William R Schief; Bruno E Correia; James E Crowe; Jens Meiler; Rocco Moretti
Journal:  Biochemistry       Date:  2021-03-11       Impact factor: 3.162

6.  A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure.

Authors:  Jeong Hyun Lee; Raiees Andrabi; Ching-Yao Su; Anila Yasmeen; Jean-Philippe Julien; Leopold Kong; Nicholas C Wu; Ryan McBride; Devin Sok; Matthias Pauthner; Christopher A Cottrell; Travis Nieusma; Claudia Blattner; James C Paulson; Per Johan Klasse; Ian A Wilson; Dennis R Burton; Andrew B Ward
Journal:  Immunity       Date:  2017-04-18       Impact factor: 31.745

7.  Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier.

Authors:  Mattia Bonsignori; Eric Scott; Kevin Wiehe; David Easterhoff; S Munir Alam; Kwan-Ki Hwang; Melissa Cooper; Shi-Mao Xia; Ruijun Zhang; David C Montefiori; Rory Henderson; Xiaoyan Nie; Garnett Kelsoe; M Anthony Moody; Xuejun Chen; M Gordon Joyce; Peter D Kwong; Mark Connors; John R Mascola; Andrew T McGuire; Leonidas Stamatatos; Max Medina-Ramírez; Rogier W Sanders; Kevin O Saunders; Thomas B Kepler; Barton F Haynes
Journal:  Immunity       Date:  2018-12-11       Impact factor: 43.474

8.  Neutralizing Antibody Induction Associated with a Germline Immunoglobulin Gene Polymorphism in Neutralization-Resistant SIVsmE543-3 Infection.

Authors:  Yuto Nomura; Saori Matsuoka; Midori Okazaki; Takeo Kuwata; Tetsuro Matano; Hiroshi Ishii
Journal:  Viruses       Date:  2021-06-21       Impact factor: 5.048

9.  HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.

Authors:  Celia C LaBranche; Andrew T McGuire; Matthew D Gray; Shay Behrens; Peter D Kwong; Xuejun Chen; Tongqing Zhou; Quentin J Sattentau; James Peacock; Amanda Eaton; Kelli Greene; Hongmei Gao; Haili Tang; Lautaro G Perez; Xuejun Chen; Kevin O Saunders; Peter D Kwong; John R Mascola; Barton F Haynes; Leonidas Stamatatos; David C Montefiori
Journal:  PLoS Pathog       Date:  2018-11-05       Impact factor: 6.823

Review 10.  Immunoglobulin germline gene variation and its impact on human disease.

Authors:  Ivana Mikocziova; Victor Greiff; Ludvig M Sollid
Journal:  Genes Immun       Date:  2021-06-26       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.